Introduction
Proteolytic processing of large precursor polyproteins by virus-encoded proteases is a central feature of the replication strategy adopted by many RNA viruses (Ishihama & Barbier, 1994 ; Spall et al., 1997 ; Dougherty & Semler, 1993) . This process has been extensively studied for many picornavirus superfamily members including poliovirus (Jore et al., 1988 ; Ypma-Wong et al., 1988 a ; Baum et al., 1991 ; Ha$ mmerle et al., 1991 ; Kean et al., 1991) , potyviruses (Carrington et al., 1989 Dougherty & Parks, 1991 ; Parks et al., 1995 ; Verchot et al., 1991) , comoviruses (Dessens & Lomonossoff, 1991 ; Peters et al., b, 1995 and, to a lesser extent, nepoviruses (Demangeat et al., 1992 ; Margis et al., 1994 ; Author for correspondence : He! le ' ne Sanfaçon (at the Pacific AgriFood Research Centre). Fax j1 250 494 0755.
e-mail sanfaconh!em.agr.ca 1995 ; Hemmer et al., 1995) . Tomato ringspot nepovirus (TomRSV) has a bipartite, single-stranded, positive-sense RNA genome. Each RNA is covalently attached to a small virusencoded protein (VPg, viral genome-linked protein) at the 5h end. Nepoviruses have been subdivided into three subgroups (Mayo & Robinson, 1996) and TomRSV is the only member of nepovirus subgroup c for which the entire nucleotide sequence is known. RNA-1 contains a single long open reading frame beginning at an AUG codon at nucleotide position 78 (Rott et al., 1995) . Based on amino acid sequence comparisons between the C-terminal portion of the TomRSV RNA-1-encoded polyprotein (P1) and polyproteins encoded by several members of the picornavirus superfamily, it has been predicted that RNA-1 encodes an NTP-binding protein (NTB), a VPg, a 3C-like protease (Pro) and an RNA-dependent RNA polymerase (Pol) (Rott et al., 1995) .
The TomRSV 3C-like protease is responsible for processing of at least one cleavage site on the P2 precursor polyprotein encoded by RNA-2 and is likely to process P1 as well. Crystal structures of 3C proteases reveal similarities to the chymotrypsin-like serine proteases (Allaire et al., 1994 ; Matthews et al., 1994) . The catalytic triad consists of histidine, glutamate (or aspartate) and cysteine (Bazan & Fletterick, 1988 ; Dougherty et al., 1989 ; Gorbalenya et al., 1989 ; Dessens & Lomonossoff, 1991 ; Margis & Pinck, 1992) . The 3C and 3C-related proteases also contain a substratebinding pocket which determines the cleavage site specificity (Bazan & Fletterick, 1988 ; Dougherty et al., 1989 ; Gorbalenya et al., 1989 ; Nienaber et al., 1993 ; Allaire et al., 1994 ; Matthews et al., 1994) . In particular, a histidine residue located in the Cterminal region of the protease is directly involved in the recognition of a glutamine (or glutamate) residue at the k1 position of the cleavage sites of picorna-, poty-and comovirus polyproteins (Bazan & Fletterick, 1988 ; Gorbalenya et al., 1989 ; Allaire et al., 1994 ; Matthews et al., 1994 ; Ivanoff et al., 1986 ; Dougherty et al., 1989 ; . The proteases of nepoviruses of subgroups a and b do not contain a histidine residue in their substrate-binding pockets and recognize cleavage sites that differ from the (Q, E)\(G, S, M) consensus of the aforesaid polyproteins (see Mayo & Robinson, 1996 ; Sanfaçon, 1995 and references therein) . We previously reported that the cleavage site between the TomRSV movement protein and coat protein is Q\G and suggested that the cleavage sites of the TomRSV polyprotein more closely resemble the picorna-, como-and potyvirus cleavage sites than the cleavage sites of polyproteins from nepoviruses of subgroups a and b . In this study, we report that the TomRSV 3C-like protease can process P1 polyprotein precursors in E. coli and in vitro. We also identify several cleavage sites on the P1 polyprotein.
Methods
Plasmid construction. Plasmid pMR10 containing the cDNA clone for the entire RNA-1 has been described (Rott et al., 1995) . To construct plasmid pT7-NTB-VPg-Pro (Fig. 1) , a fragment of pMR10 was amplified by PCR with Pfu polymerase (Stratagene) using oligonucleotides W030 (Table 1) and W023, digested with NcoI and SalI and inserted into the corresponding sites of plasmid pCITE-4a(j) (Novagen). To construct plasmid pT7-NTB-VPg-Pro H"#)$D , the large PstI-BamHI fragment of plasmid pT7-NTB-VPg-Pro was ligated with the small PstI-BamHI fragment of plasmid pET15bVPg-Pro-N-Pol H"#)$D (see below). Plasmid pT7-NTB-∆Q-VPg-Pro was constructed by self-ligation of a fragment of plasmid pT7-NTB-VPg-Pro obtained by PCR amplification using oligonucleotides W045 and W046 and Pfu polymerase.
To obtain clone pET21aMid-NTB, an EcoRI-XhoI fragment of pMR10 (TomRSV RNA-1 nt 2658-3393) was ligated into the corresponding sites of vector pET-21a (Novagen).
To construct plasmids pET15bVPg-Pro-N-Pol, pET15bVPg-Pro H"#)$D -N-Pol and pET15bVPg-Pro H"%&"L -N-Pol, the NcoI-EcoRI fragments (TomRSV RNA-1 nt 3714-4601) of plasmids pT7-Pro, pT7-Pro H"#)$D and pT7-Pro H"%&"L were first inserted into the corresponding sites of plasmid pMTL23 (Chambers et al., 1988) to allow the introduction of a stop codon. The NcoI-NdeI fragments were extracted from these intermediate plasmids and inserted into the corresponding sites of the pET-15b polylinker (Novagen).
To construct clone pET15bPro-N-Pol, an 816 nt fragment (TomRSV nt 3794-4601) was amplified from plasmid pT7-Pro with Taq DNA polymerase (Gibco-BRL) using oligonucleotides 18 and W037, digested with NcoI and EcoRI and used to replace the corresponding fragment of plasmid pET15bVPg-Pro-N-Pol.
Plasmids pT7-VPg-Pro-N-Pol-II and pT7-VPg-Pro H"#)$D -N-Pol-II were constructed by ligating a 417 nt BamHI-EcoRI fragment from clone pMR10 (TomRSV RNA-1 nt 4436-4852) with the large BamHI-EcoRI fragment of plasmid pT7-Pro and pT7-Pro H"#)$D . To construct plasmids pT7-VPg-Pro-QS-AS -N-Pol-II and pT7-VPgPro-QM-AM -N-Pol-II, site-directed mutagenesis was performed using mutant oligonucleotides to prime synthesis on single-stranded templates of pT7-VPg-Pro-N-Pol-II generated by the M13 bacteriophage and enriched with uridine to allow selection of the mutant strand (Kunkel, 1985) . Mutations were made simultaneously in single in vitro reactions by adding equimolar amounts of oligonucleotides KC25 and KC26 to pT7-VPg-Pro-N-Pol-II single-stranded DNA.
Oligonucleotides W050 and W052 were used to amplify a fragment from pMR10 with Pfu polymerase. Plasmid pT7-VPg-Pro-N-Pol-III was obtained by ligation of three fragments : the large NcoI-SalI fragment of vector pCITE-4a(j), a 0n95 kb fragment obtained by digestion of the PCR products with NcoI and HindIII and a 0n5 kb fragment obtained by digestion of the PCR products with HindIII and SalI. A similar strategy was used to obtain plasmid pT7-Pro-N-Pol-III except that oligonucleotides W052 and W051 were used to amplify the fragment from pMR10. To obtain pT7-VPg-Pro H"#)$D -N-Pol-III and pT7-Pro H"#)$D -NPol-III, the large PstI-BamHI fragments of plasmids pT7-VPg-Pro-N-Pol-III and pT7-Pro-N-Pol-III were ligated with the small PstI-BamHI fragment of plasmid pET15bVPg-Pro H"#)$D -N-Pol.
Purification of fusion proteins. Plasmids were transformed into E. coli strain JM109 (DE3) (Novagen) and protein expression was induced as described by the supplier. For protein purification, the bacterial pellet was resuspended in 10 vol. lysis buffer [50 mM Tris-HCl (pH 8), 100 mM NaCl, 1 mM EDTA], lysed in a French press and centrifuged at 5000 g for 10 min. The pellet containing the inclusion bodies was washed in lysis buffer containing 0n1 % sodium deoxycholate and 1 % NP-40. To solubilize the proteins, the purified inclusion bodies were resuspended in lysis buffer containing 8 M urea. The suspension was stirred at 4 mC for 3 h and centrifuged at 30 000 g for 45 min. To allow protein renaturation, the soluble fraction was dialysed against successively lower concentrations of urea in 50 mM Tris-HCl (pH 8).
Cross-linking of synthetic VPg peptide to ovalbumin. A peptide composed of amino acids SGSYADVYNARNMTRV, which corresponds to a part of the VPg sequence predicted to be immunogenic by the method of Hopp & Woods (1981) , was obtained from the Peptide Synthesis Laboratory, University of British Columbia, Vancouver, Canada. Lyophilized chicken egg albumin (6 mg ; Sigma) and 6 mg synthetic peptide were dissolved in conjugation buffer (0n1 M MES, pH 4n8 ; Sigma). EDC [1-ethyl-3-(3-dimethylaminopropyl) Immunological procedures. To produce MAbs against the protease (anti-Pro antibodies), BALB\c mice were immunized by subcutaneous injection using purified fusion protein (60 µg) obtained from clone pET15bPro-N-Pol as described (Wieczorek & Sanfaçon, 1993) . The fusion protocol, subsequent screening techniques and ascites fluid production were essentially as described previously (Harlow & Lane,
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1988 ; Wieczorek & Sanfaçon, 1993) . Three cell lines producing MAbs were obtained and subclassed into IgG1 isotypes using a Hybridoma Sub-Isotyping kit (Calbiochem Immunochemicals).
To raise polyclonal antibodies against NTB (anti-NTB antibodies) or VPg (anti-VPg antibodies), rabbits were injected intramuscularly with either 1 mg fusion protein obtained from clone pET21aMid-NTB or 1 mg ovalbumin cross-linked with the VPg peptide as described (Sanfaçon et al., 1995) . IgG was purified according to the protocol of Clark & Adams (1977) . To remove antibodies against ovalbumin from the anti-VPg antisera, the purified IgG was further purified by affinity chromatography using a carbohydrate\glycoprotein gel covalently linked with ovalbumin (EY Laboratories).
Proteins blots were performed essentially as described previously (Wieczorek & Sanfaçon, 1993) .
In vitro translation.
In vitro translation of the cDNA clones using a TT-coupled transcription-translation system (Promega) was performed as described by the supplier with the following modifications. After 1 h incubation at 30 mC, translation was arrested by addition of 10 µl Tris-HCl (0n1 M, pH 8) containing 5 U RNase (Promega), 2 U DNase (Promega) and cold -methionine (20 mM ; Sigma). Proteolytic processing was allowed to proceed by incubation of the samples at 16 mC and stopped by addition of 2i protein sample buffer (Laemmli, 1970) .
N-terminal protein microsequencing.
For microsequencing of the protease, expression products of plasmid pET15bVPg-Pro-N-Pol were separated by denaturing SDS-PAGE (Laemmli, 1970) and blotted onto a PVDF membrane (Bio-Rad). The band corresponding to the mature protease was excised and subjected to N-terminal amino acid sequencing (Protein Microsequencing Laboratory, Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada). For microsequencing of the VPg, viral RNA was purified from infected plants as described by . Viral RNA (1 mg) was hydrolysed in 150 µl 20 % trifluoroacetic acid (Sigma) for 48 h at room temperature. The hydrolysed material was directly subjected to microsequencing. For microsequencing of the polymerase, in vitro translation of clone pT7-VPg-Pro-N-Pol-II was performed in the presence of tritiated leucine (NEN) and the products were separated by SDS-PAGE. The region of the gel running at the position corresponding to the mature polymerase was excised. The protein was electro-eluted from the gel slices, transferred to a PVDF membrane using a Pro-Spin column (Applied Biosystems) and subjected to microsequencing.
Results
Production of MAbs and polyclonal antibodies against viral proteins
To study the proteolytic processing of P1 polyprotein, antibodies were raised against fusion proteins containing the entire protease and the middle portion of the NTB-coding region fused to a few amino acids from the expression vector (see plasmids pET15bPro-Pol and pET21aMid-NTB ; Fig. 1 ). After expression of the fusion proteins in E. coli at 37 mC, prominent polypeptides of an apparent molecular mass corresponding to the expected size for the protease (31n5 kDa) and for the middle portion of NTB (31 kDa) were detected ( Fig.  2 a, b, lane 3) . Chimeric proteins were found predominantly in the insoluble fraction (Fig. 2 a, b , lane 5). After resolubilization of inclusion bodies, fusion protein products constituted approximately 95 % of the proteins (Fig. 2 a, b, lane 6) . These Proteins were separated on 12 % polyacrylamide-SDS gels and stained with Coomassie brilliant blue R-250 (lanes 1-6) or transferred to PVDF membranes for immunodetection. Mr, molecular mass markers ; Unind and Ind, extracts from uninduced and induced E. coli cells, respectively ; Sol and Insol, soluble and insoluble fractions from induced E. coli cell extracts, respectively ; Pur, purified protein resolubilized from inclusion bodies ; lane 7, immunodetection of the fusion protein by MAbs against the protease. (b) Expression of the middle portion of NTB from clone pET21aMID-NTB. Proteins were analysed as in (a). Lanes 1-6 were as in (a) ; lane 7, immunodetection of the fusion protein by the polyclonal antibodies against the middle portion of NTB. (c) Test of polyclonal antibodies against VPg. Proteins were separated on 15 % polyacrylamide-SDS gels and transferred to PVDF membranes. The membranes were subjected to staining as in (a) and (b) or immunodetection. Mr, molecular mass markers ; ova, ovalbumin ; p-ova, VPg-derived peptide cross-linked with ovalbumin ; VPg-pro, fusion protein expressed from clone pET15bVPg-Pro-N-Pol containing the VPg domain. Lanes 1-4, staining of the blotted proteins ; lanes 5-7, immunodetection of the blotted proteins by the purified polyclonal antibodies against VPg.
preparations were used for antibody production. MAbs produced by cell line 3A10, which gave the strongest immunoreaction with the protease (Fig. 2 a, lane 7) , were used in subsequent experiments. The epitope recognized by these antibodies was mapped to the middle part of the protease (results not shown). Rabbit anti-NTB polyclonal antibodies were obtained that recognized the corresponding fusion proteins in Western immunoblots (Fig. 2 b, lane 7) . Rabbit anti-VPg polyclonal antibodies were produced against a synthetic peptide predicted to be immunogenic and cross-linked with ovalbumin. The antisera purified by affinity chromatography reacted strongly with VPg-Pro and with the synthetic peptide cross-linked with ovalbumin, but not with ovalbumin alone (Fig. 2 c, lanes 5-7) .
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Proteolytic processing of VPg-Pro-Pol precursors by the TomRSV protease in E. coli and in vitro
To determine if the TomRSV protease was able to cleave itself from its precursors, polyprotein precursors were designed that encompass the VPg, the entire protease and the Nterminal portion of the polymerase, and included the predicted VPg-Pro and Pro-Pol cleavage sites. Autocatalytic activity of the protease was tested with two different expression systems : the E. coli pET expression system (Novagen) and the TT-coupled transcription-translation rabbit reticulocyte system (Promega). For expression in E. coli, a cDNA fragment containing the corresponding coding region (including a region of Pol with an expected molecular mass of 4n5 kDa) was inserted into an expression vector to give plasmid pET15bVPg-Pro-N-Pol (Fig. 3 a) . Two mutant derivatives of this plasmid were also constructed. In clone pET15bVPg-Pro H"#)$D -N-Pol, H"#)$, which is postulated to be the base component of the catalytic triad, was replaced with aspartic acid. In clone pET15bVPg-Pro H"%&"L -N-Pol, H"%&", which is predicted to be located in the putative substrate-binding pocket, was replaced by leucine. These mutations were previously found to inactivate the protease activity on a P2 precursor in vitro . Expression of these fusion proteins was performed at 20 mC for 3 h. A protein of approximately 34n5 kDa, corresponding to the predicted size for the VPg-Pro-N-Pol precursor, was detected in extracts from induced cells containing clones pET15bVPg-Pro H"#)$D -N-Pol and pET15bVPg-Pro H"%&"L -N-Pol (Fig. 3 b) , indicating that this fusion protein was stably expressed in E. coli. The 34n5 kDa protein was recognized by both anti-VPg and antiPro antibodies in immunoblot experiments, confirming that it was the precursor containing VPg (3 kDa) and Pro (27 kDa) and probably also the Pol region (4n5 kDa) (Fig. 3 b, lanes 7 and  11) . In extracts from induced cells containing the wild-type clone, the 34n5 kDa protein was barely detectable, while two smaller proteins with apparent molecular masses of 30 and 27 kDa were prominent (Fig. 3 b) . The 30 kDa protein was recognized by both anti-VPg and anti-Pro antibodies and corresponded to the predicted size for the VPg-Pro, suggesting that it was the result of cleavage at the Pro-Pol site (Fig. 3 b,  lanes 5 and 9) . The 27 kDa protein was detected by anti-Pro antibodies but not by anti-VPg antibodies. This protein is of the expected size for the mature protease, suggesting that it was the result of further proteolytic processing between VPg and Pro. Microsequencing of the N terminus of the 27 kDa protein supported this conclusion (see below). The Pro-N-Pol precursor (predicted molecular mass of 31n5 kDa), which could have arisen by cleavage of VPg-Pro-N-Pol at the VPg-Pro cleavage site, was not detected by anti-Pro antibodies. These results suggest that the VPg-Pro-N-Pol precursor can be processed by the TomRSV protease in E. coli. This processing only occurred in precursors which contained the wild-type A. Wang and others A. Wang and others protease and did not occur in precursors with the mutated protease.
To study proteolytic processing of P1 precursor proteins in vitro, plasmid pT7-VPg-Pro-N-Pol-III was created to contain the coding region for VPg, Pro and a region of Pol with an expected molecular mass of 24 kDa (Fig. 4 a) . Upon translation in the coupled transcription-translation system, plasmid pT7-VPg-Pro-N-Pol-III generated a protein of approximately 57 kDa which corresponds to the predicted size of the VPgPro-N-Pol precursor (Fig. 4 b, lane 1) . After incubation of the 57 kDa precursor at 16 mC, a protein of 33 kDa was detected, which corresponds to the predicted size for the VPg-Pro [3 kDa fortuitous amino acids encoded by the vector sequence (VS), 3 kDa VPg, 27 kDa Pro] (Fig. 4 b, lanes 2-5) . This protein could not be observed upon incubation at 16 mC of a precursor containing a protease mutated in the catalytic triad (Fig. 4 b,  lane 7) , demonstrating that it was formed as a result of protease activity. An additional protein with an apparent molecular mass of 30 kDa was also detected in very small quantities upon incubation of the precursor containing the wild-type protease. The origin of this protein is not clear. It could have arisen by processing at the Pro-Pol site of a precursor produced from an internal initiation event. Alternatively, it may be the result of an aberrant migration of the mature protease (predicted molecular mass of 27 kDa). The small amounts of this protein and its close proximity to another labelled protein in SDS-PAGE did not allow for direct N-terminal sequencing experiments or for immunoprecipitation experiments that could have resolved this question. A protein corresponding to the Pol cleavage product (predicted molecular mass of 24 kDa) was not detected, presumably due its intrinsic instability.
In an attempt to stabilize and visualize the polymerase cleavage products, plasmid pT7-VPg-Pro-N-Pol-II, which contained a smaller portion of the polymerase fused to some vector sequence, was constructed (Fig. 5 a) . After incubation of in vitro translation products, a protein of 50 kDa, corresponding to the predicted size for the precursor polyprotein (3 kDa VPg, 27 kDa Pro, 12 kDa Pol, 6 kDa VS), was processed to give two proteins of apparent molecular masses of 30 kDa (which corresponds to the predicted size for VPg-Pro) and 22 kDa (Fig. 5 b, lane 2) . N-terminal microsequencing of the 22 kDa protein indicated that it was the polymerase moiety (predicted molecular mass of 18 kDa) (see below). This protein was not always detected, probably because of its instability. Processing was not observed in plasmid pT7-VPg-Pro H"#)$D -N-Pol-II, which contains a mutated protease (Fig. 5 b, lane 4) .
The presence of the VPg domain on VPg-Pro-Pol precursors increases cleavage efficiency at the Pro-Pol cleavage site
The presence of VPg domains on cowpea mosaic comovirus (CPMV) has been shown to influence cleavage at the Pro-Pol cleavage site (Dessens & Lomonossoff, 1992) . To determine if the VPg domain on a TomRSV precursor has an effect on processing at the Pro-Pol cleavage site, derivatives of clone pT7-VPg-Pro-N-Pol-III and pET15bVPg-Pro-N-Pol were constructed in which the VPg sequence was precisely deleted (see clones pT7-Pro-N-Pol-III and pET15bPro-N-Pol, Fig. 1 ). The efficiency of processing at the Pro-Pol site was compared in precursors that did or did not include the VPg protein. efficiency at the Pro-Pol cleavage site in precursors pT7-VPgPro-N-Pol-III and pT7-Pro-N-Pol-III in vitro. As shown above, the VPg-Pro-N-Pol-III precursors were cleaved at the Pro-Pol site to release the VPg-Pro product (Fig. 4 b, lanes 2-5) . In vitro translation of pT7-Pro-N-Pol-III resulted in the synthesis of a protein of approximately 54 kDa corresponding to the predicted size for the Pro-N-Pol-III precursor (3 kDa VS, 27 kDa Pro, 24 kDa Pol ; Fig. 4 b, lane 8) . Cleavage of this precursor at the Pro-Pol site should release a protein with a predicted molecular mass of 30 kDa, which would correspond to the mature protease. However, this protein was not detected upon incubation of the Pro-N-Pol-III precursor (Fig. 4 b, lanes 9-12) suggesting that the Pro-N-Pol-III precursor was inefficiently cleaved at the Pro-Pol site in vitro. To test whether the Pro-NPol-III precursor protease had retained its proteolytic activity, non-labelled translation products of plasmid pT7-Pro-N-Pol-III were incubated with the MPCAT substrate which contains a cleavage site from the P2 polyprotein . Efficient cleavage was detected (data not shown).
The efficiency of processing at the Pro-Pol site was compared for precursors VPg-Pro-N-Pol and Pro-N-Pol in E. coli. Anti-Pro antibodies could detect a protein of approximately 31n5 kDa in extracts from the induced cells containing clone pET15bPro-N-Pol, which was of the predicted size for the Pro-N-Pol precursor, and a protein of 27 kDa, which comigrated with a protein identified as the mature Pro (see above) ( Fig. 3 b, lane 6 ). This indicated that the Pro-N-Pol precursor was cleaved at the Pro-Pol cleavage site in E. coli. Inductions of E. coli cells containing clone pET15bVPg-Pro-NPol or pET15bPro-N-Pol were performed in parallel. Less than half of the Pro-N-Pol precursor was cleaved (compare the relative intensities of the bands corresponding to the Pro-NPol precursor and the mature protease ; Fig. 3 b, lane 6) . In contrast, most of the VPg-Pro-N-Pol precursor was processed at the Pro-Pol cleavage site [compare the relative intensities of the bands corresponding to the VPg-Pro-N-Pol precursor to the two products (VPg-Pro and Pro) ; Fig. 3 b, lane 5] . Taken together, these results suggest that the presence of the VPg domain on the precursor results in increased processing at the Pro-Pol cleavage site in vitro and in E. coli.
Proteolytic processing of an NTB-VPg-Pro precursor by the TomRSV protease in vitro
Proteolytic cleavage of the VPg-Pro-Pol precursor resulted in accumulation of the VPg-Pro intermediate. To examine if processing of different precursors would also result in accumulation of the VPg-Pro intermediate, proteolytic processing of an NTB-VPg-Pro precursor was tested in vitro. A cDNA fragment containing the corresponding coding region for NTB, VPg and Pro was inserted into vector pCITE-4a(j) to obtain plasmid pT7-NTB-VPg-Pro (Fig. 6 a) . A precursor protein of approximately 99 kDa corresponding to the predicted size for the NTB-VPg-Pro precursor protein (66 kDa NTB, 3 kDa VPg, 27 kDa Pro, 3 kDa VS) was generated by the cell-free translation system (Fig. 6 b, lane 1) . After incubation at 16 mC for 20 h, the amounts of two smaller proteins of 66 and 33 kDa increased. These corresponded to the predicted sizes for the mature NTB (66 kDa) and VPg-Pro (3 kDa VPg, 27 kDa Pro, 3 kDa VS), respectively (Fig. 6 b, lane 2) . Indeed, the 66 kDa protein could be immunoprecipitated with anti-NTB antibodies and the 33 kDa protein could be immunoprecipitated with anti-VPg and anti-Pro antibodies (data not shown). These proteins were not detected upon incubation of the translation products of plasmid pT7-NTB-VPg-Pro H"#)$D . Deletion of the conserved glutamine at the k1 position of the predicted NTB-VPg cleavage site (Rott et al., 1995) also eliminated processing (Fig. 6 b, lane 6) . The predicted NTBVPg intermediate (69 kDa) and mature Pro (27 kDa Pro, 3 kDa VS), which would have resulted from cleavage of the NTBVPg-Pro precursor at the VPg-Pro cleavage site, were not detected.
Identification of the NTB-VPg, VPg-Pro and Pro-Pol cleavage sites
To identify the cleavage site at the N terminus of VPg, the VPg protein was purified from infected plants and subjected to N-terminal microsequencing. The protein contains 27 amino acids of which 26 were identified from the N terminus. The last amino acid was deduced as a Q based on the nucleotide sequence of the TomRSV RNA-1 cDNA clone (Rott et al., 1995) . The VPg sequence was : STIPSGSYADVYNARNMARVFRPQSVq. This sequence closely matches a portion of amino acid sequence of the P1 polyprotein deduced from the nucleotide sequence of the RNA-1 cDNA clone (nt 3714-3794) (Rott et al., 1995) . The only difference observed with the published TomRSV sequence was the replacement of threonine at position 18 by alanine. The NTB-VPg cleavage site is Q"#"#\S"#"$ as deduced from the nucleotide sequence of the RNA-1 cDNA clone and predicted by Rott et al. (1995) . Two possible cleavage sites were predicted at the C terminus of the VPg protein (Rott et al., 1995) . Processing at Q"#$'\S"#$( would result in a VPg protein of 24 amino acids, while processing at Q"#$*\G"#%! would result in a VPg protein of 27 amino acids. Our results are consistent with Q"#$*\G"#%! being the VPg-Pro cleavage site.
To directly determine the VPg-Pro cleavage site, Nterminal microsequencing of the mature protease was carried out. The mature protease was isolated from E. coli cell extracts after proteolytic cleavage of the VPg-Pro-N-Pol precursor. The band stained by Coomassie blue that corresponded to the position of the 27 kDa protein recognized by anti-Pro MAbs and not by anti-VPg polyclonal antibodies was subjected to microsequencing. The sequence of the N terminus of the protease was determined to be GSSLAEAQ, which is identical to a section of sequence deduced from the TomRSV cDNA clone. The VPg-Pro cleavage site was determined to be Q"#$*\G"#%!. This result is consistent with that obtained for the VPg from infected plants, suggesting that processing of P1 precursors occurs at the same site at the VPg-Pro junction in E. coli and in infected plants.
Upon examination of the sequence at the C terminus of the protease domain, two potential cleavage sites were identified : Q"%'&\M"%'' (predicted by Rott et al., 1995) and Q"%)'\S"%)(. Mutagenesis of the two potential cleavage sites was performed on plasmid pT7-VPg-Pro-N-Pol-II, resulting in plasmids pT7-VPg-Pro-QS-AS -N-Pol-II (Q"%)' mutated to A) and pT7-VPgPro-QM-AM -N-Pol-II (Q"%'& mutated to A). Only the 50 kDa precursor was observed in the radiolabelled polypeptides generated from pT7-VPg-Pro-QS-AS -N-Pol-II (Fig. 5 b , lanes 5 and 6), indicating that processing did not occur in this mutant. In contrast, the 50 kDa precursor and the 30 and 22 kDa cleavage products could be visualized from clone pT7-VPgPro-QM-AM -N-Pol-II (Fig. 5 b, lanes 7-8) . These results suggest that Q"%)'\S"%)( corresponds to the Pro-Pol cleavage site. To directly sequence the N-terminal portion of Pol, in vitro translation of clone pT7-VPg-Pro-N-Pol-II was performed in the presence of tritiated leucine and the 22 kDa protein was subjected to microsequencing. The presence of a single peak of radioactivity at residue 7 was consistent with the first amino acid of Pol being S"%)( (Fig. 5 c) .
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Discussion
In this paper, we report proteolytic processing of TomRSV protease precursors in vitro and in E. coli. Although we could detect cleavage at all cleavage sites in E. coli, several lines of evidence suggest that cleavage at the VPg-Pro cleavage site was inefficient in all the precursors studied, both in E. coli and in vitro. Firstly, proteolytic processing of a number of precursors (NTB-VPg-Pro, VPg-Pro-N-Pol, VPg-Pro-N-Pol-II and VPg-Pro-N-Pol-III) resulted in accumulation of the VPgPro precursor in E. coli and in vitro. Proteolytic processing of larger precursors containing the NTB-VPg-Pro-Pol sequences in vitro and in E. coli also resulted in the accumulation of the VPg-Pro intermediate (data not shown). Secondly, intermediate precursors resulting from cleavage at the VPg-Pro cleavage site were not detected (such as the Pro-N-Pol intermediate for clones pET15bVPg-Pro-N-Pol, pT7-VPg-Pro-N-Pol-II, pT7-VPg-Pro-N-Pol-III, or the NTB-VPg intermediate for clone pT7-NTB-VPg-Pro). Our inability to detect these intermediates was most probably not due to their intrinsic instability, as demonstrated by stable expression of the Pro-NPol precursor in E. coli (Fig. 3 , lane 6) and in vitro (Fig. 4 b, lanes  8-14) . Similarly, Margis et al. (1994) reported that maturation of the VPg-Pro intermediate precursor of grapevine fanleaf virus (GFLV) occurred at very low rates in vitro. Also, the potyvirus NIa protein was very inefficiently cleaved at the VPg-Pro site in vitro and in E. coli (Dougherty & Parks, 1991 ; Laliberte! et al., 1992) . In contrast, the VPg-Pro-Pol precursor of tomato black ring nepovirus was found to accumulate in vitro and in vivo, indicating inefficient cleavage at both the VPg-Pro and Pro-Pol cleavage sites (Demangeat et al., 1992 ; Hemmer et al., 1995) . TomRSV VPg-Pro contains protease activity on a P2 substrate recognized in trans . Differential activities of VPg-Pro and Pro on P2 substrates were observed for two nepoviruses (Margis et al., 1994 ; Hemmer et al., 1995) . Further experiments will be necessary to determine if the TomRSV VPg-Pro precursor accumulates in .
infected plants and if the presence of VPg on the TomRSV protease influences its activity in trans on P2 substrates. We have shown that the presence of the VPg sequence on the precursor resulted in an increase in processing efficiency at the Pro-Pol cleavage site in E. coli and in vitro. Previously, the presence of the VPg on CPMV B RNA-encoded polyprotein precursors was found to enhance processing at the Pro-Pol cleavage site (Dessens & Lomonossoff, 1992) . In contrast, the presence of the VPg domain on the VPg-Pro-Pol precursor of GFLV did not influence cleavage at the Pro-Pol site (Margis et al., 1994) . One likely explanation for this is that the presence of VPg on the precursor would result in a conformational change that would favour processing at the TomRSV and CPMV Pro-Pol cleavage sites. It is also possible that other sequences on P1, not included in the precursors studied here, may influence cleavage at the VPg-Pro or other cleavage sites.
We have identified three new dipeptide cleavage sites, i.e. Q\S between NTB and VPg, Q\G between VPg and Pro, and Q\S between Pro and Pol. Previously, the sequence of the TomRSV polyprotein cleavage site between the movement protein and the coat protein (Q\G) was determined . Deletion or mutation (to alanine) of the glutamine at the k1 position abolished processing at the NTB-VPg and Pro-Pol cleavage sites, suggesting that this amino acid plays a critical role in the cleavage site specificity of the protease. The specificity of cleavage by the picorna-, potyand comovirus proteases is for peptide bonds between glutamine (or glutamic acid) and residues with small side chains (Wellink et al., 1986 ; Hellen et al., 1989 ; Palmenberg, 1990 ; Dougherty et al., 1988) . Our results are fully consistent with those known cleavage sites and support our previous suggestion that TomRSV protease cleavage sites are more related to the cleavage sites of the poty-, como-and picornavirus proteases than to the cleavage sites recognized by subgroup a and b nepovirus proteases . In addition to the conserved dipeptide, the primary sequence and the secondary structure around the cleavage site are important A. Wang and others A. Wang and others factors in determining the efficiency of cleavage by the protease (Dougherty et al., 1988 ; Garcia et al., 1992 ; YpmaWong et al., 1988 b) . For example, small neutral side chain amino acids (alanine, leucine, valine, isoleucine) are conserved at the k4 position of most cleavage sites recognized by the polio-, como-and potyvirus proteases (Wellink et al., 1986 ; Dougherty et al., 1988 ; Nicklin et al., 1986 ; Blair & Semler, 1991) . Comparison of four TomRSV cleavage sites did not reveal any consensus sequence at the k4 position. In contrast, a valine at the k2 position was present in three of the cleavage sites and a serine or threonine at the k3 position was present in three of the cleavage sites ( Table 2 ). Mutagenesis of these amino acids will be necessary to determine if they play an important role in the recognition of the cleavage site by the TomRSV protease. Determination of the NTB-VPg, VPg-Pro and Pro-Pol cleavage sites allowed precise localization of the VPg, Pro and Pol domains on the TomRSV RNA-1-encoded polyprotein. As deduced from the RNA-1 sequence, VPg, Pro and Pol have calculated molecular masses of 3n02, 26n80 and 80n5 kDa, respectively.
